PubMed:15630069 / 1941-2340
Annnotations
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
1356 | 102-111 | ChemicalEntity | denotes | clozapine | MESH:D003024 |
1357 | 112-122 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
1358 | 123-134 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
1359 | 164-173 | ChemicalEntity | denotes | clozapine | MESH:D003024 |
1360 | 178-188 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
1361 | 212-230 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | MESH:D007333 |
1362 | 276-287 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
1363 | 289-298 | ChemicalEntity | denotes | clozapine | MESH:D003024 |
1364 | 302-313 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
1365 | 338-348 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
1366 | 352-363 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17 | 0-399 | Sentence | denotes | There was a significant difference in insulin sensitivity index among groups (F(33) = 10.66; P<.001) (clozapine<olanzapine<risperidone), with subjects who received clozapine and olanzapine exhibiting significant insulin resistance compared with subjects who were treated with risperidone (clozapine vs risperidone, t(33) = -4.29; P<.001; olanzapine vs risperidone, t(33) = -3.62; P = .001 [P<.001]). |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T26 | 38-45 | GeneOrGeneProduct | denotes | insulin |
T27 | 212-219 | GeneOrGeneProduct | denotes | insulin |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 38-45 | GeneOrGeneProduct | denotes | insulin |
T15 | 212-219 | GeneOrGeneProduct | denotes | insulin |
LitCoin-Disease-MeSH
Id | Subject | Object | Predicate | Lexical cue | originalLabel |
---|---|---|---|---|---|
T10 | 38-57 | DiseaseOrPhenotypicFeature | denotes | insulin sensitivity | D007333 |
T11 | 212-230 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |
LitCoin_Mondo_095
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T12 | 46-57 | DiseaseOrPhenotypicFeature | denotes | sensitivity | 0000605 |
LitCoin-MeSH-Disease-2
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T10 | 38-57 | DiseaseOrPhenotypicFeature | denotes | insulin sensitivity | D007333 |
T11 | 212-230 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |
LitCoin-MONDO_bioort2019
Id | Subject | Object | Predicate | Lexical cue | #label |
---|---|---|---|---|---|
T9 | 212-230 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T57 | 102-111 | ChemicalEntity | denotes | clozapine | D003024|http://purl.obolibrary.org/obo/CHEBI_3766 |
T59 | 112-122 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
T61 | 123-134 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
T63 | 164-173 | ChemicalEntity | denotes | clozapine | D003024|http://purl.obolibrary.org/obo/CHEBI_3766 |
T65 | 178-188 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
T67 | 276-287 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
T69 | 289-298 | ChemicalEntity | denotes | clozapine | D003024|http://purl.obolibrary.org/obo/CHEBI_3766 |
T71 | 302-313 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
T73 | 338-348 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
T75 | 352-363 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
---|---|---|---|---|---|---|
T75 | 352-363 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
T73 | 338-348 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
T71 | 302-313 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
T69 | 289-298 | ChemicalEntity | denotes | clozapine | http://purl.obolibrary.org/obo/CHEBI_3766|D003024 | |
T67 | 276-287 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
T65 | 178-188 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
T63 | 164-173 | ChemicalEntity | denotes | clozapine | http://purl.obolibrary.org/obo/CHEBI_3766|D003024 | |
T61 | 123-134 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
T59 | 112-122 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
T57 | 102-111 | ChemicalEntity | denotes | clozapine | http://purl.obolibrary.org/obo/CHEBI_3766|D003024 | |
T9 | 212-230 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |